Diamond Member Pelican Press 0 Posted September 13, 2024 Diamond Member Share Posted September 13, 2024 This is the hidden content, please Sign In or Sign Up Neurocrine halts development of schizophrenia ***** as trial fails, ET HealthWorld data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw== London: Neurocrine Biosciences said on Thursday it will halt the development of its experimental *****, aimed at improving cognitive function in patients with schizophrenia, after it did not achieve the primary goal in a mid-stage trial. The company said the *****, luvadaxistat, did not replicate the results from a previous mid-stage trial that showed improved cognitive performance, due to a large variability in the cognitive measures across the patients and a potential imbalance in their baseline characteristics. In the previous study, luvadaxistat ******* to meet the main goal of change from baseline in negative symptoms of schizophrenia, however, it met the secondary goal of improving cognitive performance. Neurocrine said it will focus its resources on late-stage development of its other schizophrenia and depression ***** candidates. Shares of the company were down 2.5 per cent in extended trading. Last month, the company said its other schizophrenia *****, NBI-1117568, helped reduce the severity of symptoms in a mid-stage trial, but there were concerns whether the benefit could be replicated in larger trials. (Reporting by Puyaan Singh; Editing by Mohammed Safi Shamsi and Shinjini Ganguli) Published On Sep 13, 2024 at 07:05 AM IST Join the community of 2M+ industry professionals Subscribe to our newsletter to get latest insights & analysis. data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw== Download ETHealthworld App Get Realtime updates Save your favourite articles data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw== data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw== Scan to download App data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw== This is the hidden content, please Sign In or Sign Up #Neurocrine #halts #development #schizophrenia #***** #trial #fails #HealthWorld This is the hidden content, please Sign In or Sign Up This is the hidden content, please Sign In or Sign Up Link to comment https://hopzone.eu/forums/topic/124984-neurocrine-halts-development-of-schizophrenia-drug-as-trial-fails-et-healthworld/ Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now